Navigation Links
Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners
Date:12/1/2009

TORONTO, Dec. 1 /PRNewswire/ - Sentinelle Medical Inc., a leading manufacturer of breast MRI coils and 4D advanced visualization software, extends its line of award winning breast coils at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 30 - Dec. 5, 2009 (Booth 5800, Hall A).

With the unique Vanguard(R) patient support design and proprietary Variable Coil Geometry(TM), Sentinelle's line of breast coils are recognized for delivering unprecedented image quality and interventional access in MRI. Dr. Bruce Porter of First Hill Diagnostic Imaging in Seattle, WA states "The extremely high signal to noise and resolution of the Sentinelle breast coil, especially for the axillary tail and nodes, clearly advances breast MR both for diagnosis and as a breast cancer staging tool." In 2008, Sentinelle released Vanguard 1.5T 8 channel offerings for GE, Siemens and Toshiba MRI systems. At RSNA 2009, Sentinelle will introduce a number of new Vanguard breast coils, expanding both the depth and breadth of offerings for each of their key partners.

The Vanguard for GE is known for its workflow-enhancing 1.5T 8 channel stretcher-based coil solution. This year, Sentinelle is showcasing a significantly expanded line of both stretcher and tabletop-based solutions that address both 1.5T and 3.0T imaging on GE's Signa(R) HDxt, Discovery(TM) and Optima(TM) MRI platforms that will ship in 2010. The lineup for the Signa(R) HDxt platform will add a 3T 8 channel stretcher and a 1.5T 8 channel tabletop offering. Sentinelle is also excited to introduce high channel count offerings for GE's new platforms with the 1.5T 16 channel Optima(TM) MR450w stretcher-based coil and the 3.0T 16 channel Discovery(TM) MR750 tabletop coil.

Sentinelle's Vanguard for Siemens product line is expanded from the current 1.5T 8 channel offerings for the MAGNETOM(R) Espree(TM), MAGNETOM(R) Avanto(TM) and MAGNETOM(R) Symphony, A Tim(TM) System to include both a value and a 3T offering. At RSNA 2009, Sentinelle will be showing the only imaging and interventional breast coil available for the MAGNETOM(R) ESSENZA(TM) platform. This coil has a number of unique features including the ability to perform angled biopsies, allowing clinicians the maximum access to the breast for interventional procedures. The Vanguard for Siemens product line will now include a new 8 channel offering for Siemens 3.0T MAGNETOM(R) Verio(TM) and MAGNETOM(R) Trio(TM) MRIs.

Sentinelle is also excited to add to the current 1.5T Vantage Atlas(TM) and Vantage Titan(TM) Vanguard for Toshiba product line with the new Vantage Titan(TM) 3T**. An offering for the 1.5T Vantage* will also be demonstrated.

In keeping with Sentinelle's reputation for innovation, a number of new product offerings will be profiled at RSNA 2009. Verity(TM), Sentinelle's angled biopsy device, enables significantly greater biopsy access over traditional grid-based approaches. Sentinelle will also be demonstrating a new MRI Prostate Imaging and Interventional Suite*. Aegis, Sentinelle's 4D Advanced Visualization Software Platform, has also been expanded to include a zero footprint Aegis Web option, and new modules enabling a host of new MRI/Ultrasound Navigation* technologies, making the most of its customers' MRI investment.

"Sentinelle remains focused on delivering clinically relevant products that better enable our customers to manage cancer." said Cameron Piron, Sentinelle's President and CEO. "It is rewarding to be able to support our partners and customers with a greatly expanded line of products that will broaden access to these important technologies."

About Sentinelle Medical Inc.

Sentinelle Medical is a leading manufacturer of breast MRI coils and 4D advanced visualization software, providing clinicians greater confidence in diagnosis and accuracy in intervention. The award winning Sentinelle Vanguard(R) breast coils for GE, Siemens and Toshiba MRIs provide excellent quality MR images, complete and open access for intervention, enhanced patient comfort and clinical workflow. Sentinelle's groundbreaking Aegis line of advanced 4D visualization software has been designed from the ground up to offer the clinician maximum control, and superior speed of interaction, within an intuitive and easy to use interface. Sentinelle's innovative product line also includes solutions for multimodality imaging, designed to solve the real world problems radiologists, technologists and oncologists encounter in their efforts for earlier detection and better treatment of cancer.

Sentinelle products are used in leading breast cancer and imaging centers throughout North America including Dartmouth-Hitchcock Medical Centre, H. Lee Moffitt Cancer Center and Research Institute, Mountain Medical Physician Specialists, Radiology Ltd., Scripps Memorial Hospital, Sunnybrook Health Sciences Centre, University Health Network and Windsong Radiology Group.

    * Aegis(TM) Navigation, Aegis Prostate are works in progress, requires
        510(k) pre-market review, and is not yet commercially available in
        the U.S.
    ** Scanner pending 510(k) clearance

SOURCE Sentinelle Medical Inc.


'/>"/>
SOURCE Sentinelle Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientifics PureWeb Technology
2. Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology
3. Sentinelle Medical Receives Frost & Sullivan Excellence in Technology Award
4. Sentinelle Medical Enters OEM Distribution Agreement with Siemens AG
5. Sentinelle Medical Enters OEM Distribution Agreement with Toshiba
6. Trending Against the Norm: How One Top Scoring Ross University Medical Student is Choosing to Make a Difference in Internal Medicine
7. CRH Medical reports Q3 2009 results
8. APR Energy Donates Medicine and Medical Services to Community of La Esperanza
9. Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence
10. Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells
11. Vanderbilt scientists report first effective medical therapy for rare stomach disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... -- Dublin ... the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global market ... its applications in various applications. The report deals with ... main industries: pharmaceutical and biotechnology, food and beverage, and ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology: